This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Acné excoriée
L12_ACNE_EXCOR
acne: An inflammatory process of the sebaceous glands which is characterized by comedones, nodules, papules and/or pustules on the skin.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
44 |
4. Check minimum number of eventsNone |
44 |
5. Include endpointsNone |
44 |
6. Filter based on genotype QC (FinnGen only) |
44 |
Control definitions (FinnGen only)
- Control exclude
- L12_DISORDSKINAPPENDIX
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L70
- Name in latin
- Acne excoriata
Similar endpoints
↥List of similar endpoints to
Acné excoriée
based on the number of shared cases.
Similar with more cases:
- Acne
- Disorders of skin appendages
- Diseases of the skin and subcutaneous tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 281 | 225 | 55 |
| Only index persons | 276 | 223 | 53 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 33.60 | 33.87 | 32.62 |
| Only index persons | 33.63 | 33.87 | 32.62 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 44 | 37 | 7 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 34.27 | 34.13 | 35.02 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
22
99
3.44
3.90
8.3
5.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
14
57
3.14
2.79
5.0
3.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
20
101
2.80
2.72
2.3
2.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
7
7.86
2.61
2.0
1.9
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
7
16
4.98
2.59
1.4
2.1
g/l
0.3
0.2
—
7
16
(3000330) Specific gravity of Urine by Test strip
5
9
6.10
2.27
7.6
4.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
20
3.96
2.15
1.7
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
26
3.52
2.13
1.5
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
8
26
3.52
2.13
1.5
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
22
3.58
1.97
1.9
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
22
3.58
1.97
1.9
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
22
3.58
1.97
2.0
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
22
3.58
1.97
1.9
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
22
132
2.33
1.96
7.4
6.9
mmol/l
1.2
1.2
0.15
16
109
(3009445) Proteinase 3 Ab [Units/volume] in Serum
6
17
3.91
1.91
1.0
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
12
4.55
1.87
2.2
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
9
38
2.71
1.57
1.6
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
15
3.62
1.57
2.0
2.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
21
3.14
1.56
2.3
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
16
91
2.19
1.56
1.3
1.3
u/ml
0.7
3.1
—
5
21
(3022145) Colonoscopy Study observation
7
28
2.78
1.52
1.4
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
9
40
2.56
1.51
1.6
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
5
16
3.38
1.48
4.8
11.3
mmol/l
9.0
8.9
—
5
16
(3000764) Benzodiazepines [Presence] in Urine
6
23
2.85
1.42
2.0
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
8
35
2.56
1.35
6.6
1.3
—
—
—
0
0
(4035726)
6
24
2.73
1.35
1.5
1.2
—
—
—
0
0
(3015736) pH of Urine
21
140
1.96
1.31
4.0
3.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
17
106
1.98
1.27
6.6
4.3
inr
1.0
1.0
—
5
36
(3020682) Albumin/Creatinine [Ratio] in Urine
13
74
2.07
1.23
5.2
3.9
mg/mmol
11.0
10.1
—
7
49
(3007164) IgA [Mass/volume] in Serum or Plasma
14
83
2.01
1.19
1.5
1.3
g/l
2.1
2.1
—
9
49
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
52
2.19
1.17
1.4
1.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
10
52
2.19
1.17
1.2
1.4
—
240.0
—
0
8
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
14
84
1.98
1.15
1.4
1.5
mg/l
0.6
0.7
—
8
61
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
43
2.05
0.94
1.5
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
31
255
1.73
0.83
6.3
3.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
15
105
1.65
0.72
4.3
3.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
42
1.79
0.72
1.4
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
28
1.88
0.68
3.6
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
28
1.88
0.68
1.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
51
1.69
0.65
2.0
1.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
20
0.00
0.62
0.0
1.5
—
1.6
—
0
12
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
11
74
1.65
0.60
1.5
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
29
327
0.67
0.52
3.9
3.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
32
1.63
0.44
4.0
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
65
1.48
0.42
1.7
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.42
0.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
16
0.00
0.42
0.0
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
34
1.53
0.42
2.8
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
10
72
1.50
0.41
4.5
3.4
mg/l
48.8
48.6
—
5
49
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
39
363
1.65
0.40
20.6
10.0
mg/l
19.2
16.2
0.21
32
263
(40768797) Stomach Pathology biopsy report
6
41
1.54
0.38
1.5
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
21
178
1.34
0.36
4.6
3.3
estimate
0.0
0.0
—
5
38
(3044889) 12 lead EKG panel
24
208
1.34
0.35
2.8
3.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
102
1.39
0.35
4.2
3.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
21
179
1.33
0.34
7.9
4.9
estimate
0.0
0.0
—
5
39
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
114
0.74
0.32
1.3
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
21
180
1.32
0.32
4.6
3.4
estimate
0.0
0.0
—
5
36
(3013512) EKG study
11
85
1.39
0.32
4.9
3.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
87
1.35
0.27
4.0
6.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
6
83
0.68
0.27
2.5
3.2
—
1.0
—
0
13
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
112
0.75
0.23
1.6
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
40
1.28
0.23
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
12
0.00
0.21
0.0
5.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
17
148
1.24
0.21
1.9
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
10
81
1.30
0.21
16.9
8.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
14
0.00
0.20
0.0
1.6
—
4.9
—
0
9
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
16
139
1.24
0.20
4.2
3.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
30
280
1.22
0.18
4.5
2.4
u/l
35.9
34.3
0.11
30
265
(3018095) Leukocytes [#/volume] in Urine
13
112
1.23
0.17
6.2
3.7
e6/l
10.1
72.1
—
8
72
(3011397) Hemoglobin [Presence] in Urine by Test strip
9
79
1.17
0.17
3.6
3.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
81
1.14
0.16
1.6
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
86
0.78
0.16
1.9
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
36
344
1.26
0.15
3.5
3.5
mmol/l
5.6
5.6
0.07
31
317
(3044640) Blood type and Crossmatch panel - Blood
12
106
1.18
0.11
2.3
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
107
1.17
0.10
1.8
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
60
0.81
0.09
1.2
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
14
128
1.14
0.08
2.1
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
87
1.04
0.07
2.0
2.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
34
331
1.12
0.04
16.2
9.1
ml/min/173m2
90.1
90.9
0.08
29
270
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
11
102
1.10
0.03
4.2
3.0
ng/l
14.6
26.5
—
6
54
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
10
94
1.08
0.01
2.8
1.7
mmol/l
2.1
1.2
—
10
78
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
17
171
0.99
0.00
3.9
3.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
11
114
0.95
0.00
1.6
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
15
146
1.04
0.00
5.3
2.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
5.9
—
1.1
—
0
7
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
8
86
0.91
0.00
5.0
3.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020891) Body temperature
0
6
0.00
0.00
0.0
7.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
36
358
1.03
0.00
24.8
10.8
%
39.7
40.5
0.61
25
288
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
-0.00
0.0
1.1
—
2.8
—
0
9
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
2.3
—
172.0
—
0
9
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
-0.00
0.0
1.1
—
0.0
—
0
9
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
-0.00
0.0
1.1
—
1.1
—
0
9
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
-0.00
0.0
1.1
—
0.0
—
0
9
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
-0.00
0.0
1.1
—
0.0
—
0
9
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
-0.00
0.0
1.1
—
40.4
—
0
9
Mortality – FinRegistry
↥Association
Association between endpoint L12_ACNE_EXCOR and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have L12_ACNE_EXCOR.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: L12_ACNE_EXCOR – Acné excoriée
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data